U.S. flag

An official website of the United States government

NM_000041.3(APOE):c.683G>A (p.Trp228Ter) AND Familial type 3 hyperlipoproteinemia

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 1, 1992
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000019445.23

Allele description

NM_000041.3(APOE):c.683G>A (p.Trp228Ter)

Gene:
APOE:apolipoprotein E [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.32
Genomic location:
Preferred name:
NM_000041.3(APOE):c.683G>A (p.Trp228Ter)
HGVS:
  • NC_000019.10:g.44908979G>A
  • NG_007084.2:g.8198G>A
  • NM_000041.3:c.683G>A
  • NP_000032.1:p.Trp228Ter
  • NC_000019.9:g.45412236G>A
  • NM_000041.2:c.683G>A
Protein change:
W210*; TRP210TER
Links:
OMIM: 107741.0014; dbSNP: rs121918396
NCBI 1000 Genomes Browser:
rs121918396
Molecular consequence:
  • NM_000041.3:c.683G>A - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Familial type 3 hyperlipoproteinemia
Identifiers:
MedGen: C0020479

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000039735OMIM
no assertion criteria provided
Pathogenic
(Nov 1, 1992)
germlineliterature only

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Familial apolipoprotein E deficiency and type III hyperlipoproteinemia due to a premature stop codon in the apolipoprotein E gene.

Lohse P, Brewer HB 3rd, Meng MS, Skarlatos SI, LaRosa JC, Brewer HB Jr.

J Lipid Res. 1992 Nov;33(11):1583-90.

PubMed [citation]
PMID:
1361196

Type III hyperlipoproteinemia associated with apolipoprotein E deficiency.

Ghiselli G, Schaefer EJ, Gascon P, Breser HB Jr.

Science. 1981 Dec 11;214(4526):1239-41.

PubMed [citation]
PMID:
6795720
See all PubMed Citations (3)

Details of each submission

From OMIM, SCV000039735.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (3)

Description

Lohse et al. (1992) studied a kindred with apolipoprotein E deficiency and a truncated low molecular weight apoE mutant, designated apoE-3(Washington). Gel electrophoresis demonstrated complete absence of the normal apoE isoproteins and the presence of a small quantity of a lower molecular weight apoE. Plasma apoE levels in the proband were approximately 4% of normal. This marked deficiency of apoE resulted in delayed uptake of chylomicron and very low density lipoprotein (VLDL) remnants by the liver, elevated plasma cholesterol levels, mild hypertriglyceridemia, and the development of type III hyperlipoproteinemia. Sequence analysis demonstrated a G-to-A transition which converted amino acid 210 of the mature protein, tryptophan (TGG), to a premature chain termination codon (TAG), thus leading to the synthesis of a truncated E apolipoprotein of 209 amino acids with a molecular mass of 23.88 kD. The nucleotide substitution also resulted in the formation of a new restriction site for MaeI. Using this enzyme, they were able to establish that the proband was a homozygote and that her 2 offspring were heterozygotes. They stated that only a single kindred with apoE deficiency had been reported previously. This was the kindred reported by Ghiselli et al. (1981) and elucidated at the molecular level by Cladaras et al. (1987); see 107741.0005.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 6, 2016